Global Immunization insights_January/February 2026

logo
Banner

Global Immunization Newsletter - January/February 2026

After the WHO Executive Board: Charting the next five years of immunization 

At the 158th session of the WHO Executive Board (2–7 February 2026), one message came through clearly: immunization remains one of the most powerful and cost-effective ways to save lives, protect communities, and strengthen health systems. Against a backdrop of significant global shifts—including financial constraints, governance reform, and evolving partnerships—Member States and partners reaffirmed the Immunization Agenda 2030 (IA2030) as the shared global strategy and partnership umbrella guiding immunization efforts in the years ahead. Discussions underscored the need for sharper prioritization, stronger accountability, and closer collaboration across the global health ecosystem. 

Looking to the next five years, the focus is firmly on turning ambition into impact. EB discussions emphasized reaching zero-dose children and under-immunized populations, embedding immunization within primary health care and universal health coverage, rebuilding trust and demand, and strengthening country ownership in a constrained financing environment. Member States also highlighted the importance of effective governance, sustainable financing, and meaningful engagement with partners and non-state actors. 

Working alongside partners such as Gavi, UNICEF, and civil society, WHO is being called upon to lead with clarity and coordination—ensuring that immunization remains central to resilient health systems and that no one, anywhere, is left unprotected. 

Read more ...

Upcoming meetings 

Meetings
  • WHO Strategic Advisory Group of Experts on Immunization 
    9-12 March 2026, Geneva, Switzerland.
  • 14th International Conference on Typhoid & Other Invasive Salmonelloses
    24-26 March 2026, Phnom Penh, Cambodia.
  • World TB Day
    27 March 2026
  • World Immunization Week
    24-30 April
  • World Malaria Day
    25 April 2026
  • TB Vaccine Accelerator Summit
    26-28 April 2026

Q&A Feature: Immunization Agenda 2030

 
Q&A on IA2030

As IA2030 reaches its midpoint, how would you assess global progress so far, and where are we most off track? 

Read more ...
 

Trusted answers on vaccines

 
Trusted answers on vaccines

Exploring WHO’s new information hub

In an era where misinformation about vaccines can spread as quickly as disease outbreaks themselves, restoring public trust in vaccination is more important than ever. 

Read more ...

Stories

 
Next-generation flu vaccines could save millions of lives

Next-generation flu vaccines could save millions of lives

Next-generation influenza vaccines could prevent 18 billion cases and save 6.2 million lives by 2050, according to a recent World Health Organization (WHO) assessment.  

Read more ...
4-Dose RTS,S boosts protection against malaria

4-Dose RTS,S boosts protection against malaria

WHO recommends two malaria vaccines, RTS,S and R21, to prevent malaria in children. Pilot programmes in Ghana, Kenya and Malawi reduced child deaths by 13%.

Read more ...
New vaccine customs classification

New vaccine customs classification

Thirty-eight new customs codes for human vaccines and other essential medical products will enter into the Harmonized System (HS) on 1 January 2028

Read more ...
Statement: Hep B birth dose vaccine trial in Guinea-Bissau

Statement: Hep B birth dose vaccine trial in Guinea-Bissau

WHO reaffirms the hepatitis B birth dose vaccine as essential and proven, and raises serious scientific and ethical concerns about the proposed trial in Guinea-Bissau.

Read more ...
Bangladesh introduces typhoid conjugate vaccines

Bangladesh introduces typhoid conjugate vaccines

Bangladesh introduced typhoid conjugate vaccines last October through a nationwide campaign reaching more than 42 million children

Read more ...

New resources

 
  • WHO guidance on the use of licensed human influenza A(H5) vaccines for the interpandemic and emergence periods 
  • Improved influenza vaccines: full value vaccine assessment
  • Second edition of the Big Catch-Up (BCU) Newsletter
  • Catalyzing solutions for equitable global access and sustainable financing for novel tuberculosis vaccines for adults and adolescents

  • Measles and Rubella Strategic Framework 2021-2030
  • Developing national meningitis plans: an operational manual
  • Noninferiority of One HPV Vaccine Dose to Two Doses. 

  • Single-dose HPV vaccination in the United States - a multi-modeling analysis.

  • 2025 WHO Global Vaccine Market Report 

Past meetings

 
Past meetings
  • WHO South‑East Asia Region hosts regional webinar on NITAG Maturity Assessment Tool
  • Civil Society Information Session: WHO TB Vaccine Accelerator Global Finance and Access Working Group for Novel TB Vaccines
  • First biannual 2026 RITAG meeting to advance immunization priorities in the Eastern Mediterranean
  • Webinar recording: Reaching Zero-Dose Children: Insights from Six Implementation Research Studies

Contributions

 
Share your immunization news by November 27

Contribute to the next issue of the GIN

To contribute to the next update, please click on this link to submit an article by the 20th of March. 
If you have any questions or feedback, please contact:
globalimmunnews@who.int

 
Approved
  Tweet 
  Forward 

World Health Organization
Department of Immunization, Vaccines & Biologicals (IVB)
Universal Health Coverage/Lifecourse Division
World Health Organization, Geneva, Switzerland

The Immunization, Vaccines and Biologicals department is responsible for targeting vaccine-preventable diseases, guiding immunization research and establishing immunization policy.

Subscribe to our newsletter

Preferences  |  Unsubscribe